118 related articles for article (PubMed ID: 20506334)
1. The enigmatic role of interleukin-12 in the pathogenesis of Sjögren's syndrome: comment on the article by Vosters et al.
Airoldi I; Di Carlo E; Pistoia V
Arthritis Rheum; 2010 Jul; 62(7):2180; author reply 2180-1. PubMed ID: 20506334
[No Abstract] [Full Text] [Related]
2. Sjögren's syndrome: immunological response underlying the disease.
Brayer JB; Humphreys-Beher MG; Peck AB
Arch Immunol Ther Exp (Warsz); 2001; 49(5):353-60. PubMed ID: 11798133
[TBL] [Abstract][Full Text] [Related]
3. Immunopathogenesis of Sjögren's syndrome.
Moutsopoulos HM
Isr J Med Sci; 1988 Dec; 24(12):737-9. PubMed ID: 3066783
[No Abstract] [Full Text] [Related]
4. Usefulness of mouse models to study the pathogenesis of Sjögren's syndrome.
Soyfoo MS; Steinfeld S; Delporte C
Oral Dis; 2007 Jul; 13(4):366-75. PubMed ID: 17577322
[TBL] [Abstract][Full Text] [Related]
5. Sjögren's syndrome in the NOD mouse model is an interleukin-4 time-dependent, antibody isotype-specific autoimmune disease.
Gao J; Killedar S; Cornelius JG; Nguyen C; Cha S; Peck AB
J Autoimmun; 2006 Mar; 26(2):90-103. PubMed ID: 16413168
[TBL] [Abstract][Full Text] [Related]
6. The possible etiopathogenic genes of Sjögren's syndrome.
Takei M; Shiraiwa H; Azuma T; Hayashi Y; Seki N; Sawada S
Autoimmun Rev; 2005 Sep; 4(7):479-84. PubMed ID: 16137615
[TBL] [Abstract][Full Text] [Related]
7. T cell subpopulations in the labial minor salivary gland histopathologic lesion of Sjögren's syndrome.
Skopouli FN; Fox PC; Galanopoulou V; Atkinson JC; Jaffe ES; Moutsopoulos HM
J Rheumatol; 1991 Feb; 18(2):210-4. PubMed ID: 1827160
[TBL] [Abstract][Full Text] [Related]
8. Chemokine receptor expression by peripheral blood B lymphocytes in patients with primary Sjögren's syndrome: comment on the article by Hansen et al.
Perucha E; Reyes E; Prieto A; Alvarez de Mon M; Rodríguez A; Zea A
Arthritis Rheum; 2006 May; 54(5):1707-8; author reply 1708. PubMed ID: 16646060
[No Abstract] [Full Text] [Related]
9. IL-14 alpha, the nexus for primary Sjögren's disease in mice and humans.
Shen L; Suresh L; Li H; Zhang C; Kumar V; Pankewycz O; Ambrus JL
Clin Immunol; 2009 Mar; 130(3):304-12. PubMed ID: 19038581
[TBL] [Abstract][Full Text] [Related]
10. An important role for B-cell activation factor and B cells in the pathogenesis of Sjögren's syndrome.
Mackay F; Groom JR; Tangye SG
Curr Opin Rheumatol; 2007 Sep; 19(5):406-13. PubMed ID: 17762603
[TBL] [Abstract][Full Text] [Related]
11. Salivary gland changes in the NOD mouse model for Sjögren's syndrome: is there a non-immune genetic trigger?
Humphreys-Beher MG; Yamachika S; Yamamoto H; Maeda N; Nakagawa Y; Peck AB; Robinson CP
Eur J Morphol; 1998 Aug; 36 Suppl():247-51. PubMed ID: 9825931
[TBL] [Abstract][Full Text] [Related]
12. M3 muscarinic acetylcholine receptor reactive IL-17 producing T cells promotes development of Sjögren's syndrome like sialadenitis.
Iizuka M; Tsuboi H; Asashima H; Hirota T; Kondo Y; Matsui M; Matsumoto I; Sumida T
Mod Rheumatol; 2015 Jan; 25(1):158-60. PubMed ID: 24593169
[No Abstract] [Full Text] [Related]
13. Lymphocytic infiltration and goblet cell marker alteration in the conjunctiva of the MRL/MpJ-Fas(lpr) mouse model of Sjögren's syndrome.
Diebold Y; Chen LL; Tepavcevic V; Ferdman D; Hodges RR; Dartt DA
Exp Eye Res; 2007 Mar; 84(3):500-12. PubMed ID: 17208228
[TBL] [Abstract][Full Text] [Related]
14. [Production and role of B cell growth factor (BCGF) in Sjögren's syndrome].
Goto Y; Ito M
Nihon Rinsho; 1995 Oct; 53(10):2418-21. PubMed ID: 8531348
[TBL] [Abstract][Full Text] [Related]
15. No evidence of an association between the interleukin-10 promoter GCC allele and primary Sjögren's syndrome: comment on the article by Hulkkonen et al.
Lester S; Limaye V; Downie-Doyle S; Pile KD; Bardy P; Gordon TP; Rischmueller M
Arthritis Rheum; 2002 Jun; 46(6):1694-6; author reply 1696-7. PubMed ID: 12115207
[No Abstract] [Full Text] [Related]
16. Central role for marginal zone B cells in an animal model of Sjogren's syndrome.
Shen L; Gao C; Suresh L; Xian Z; Song N; Chaves LD; Yu M; Ambrus JL
Clin Immunol; 2016 Jul; 168():30-36. PubMed ID: 27140729
[TBL] [Abstract][Full Text] [Related]
17. A new animal model for primary Sjögren's syndrome in NFS/sld mutant mice.
Haneji N; Hamano H; Yanagi K; Hayashi Y
J Immunol; 1994 Sep; 153(6):2769-77. PubMed ID: 8077681
[TBL] [Abstract][Full Text] [Related]
18. B-lymphocyte depletion ameliorates Sjögren's syndrome in Id3 knockout mice.
Hayakawa I; Tedder TF; Zhuang Y
Immunology; 2007 Sep; 122(1):73-9. PubMed ID: 17472721
[TBL] [Abstract][Full Text] [Related]
19. Cytokine mRNA expression in salivary gland biopsies of Sjögren's syndrome.
Fox RI; Kang HI; Ando D; Abrams J; Pisa E
J Immunol; 1994 Jun; 152(11):5532-9. PubMed ID: 8189070
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic potential for B-cell modulation in Sjögren's syndrome.
Mariette X
Rheum Dis Clin North Am; 2008 Nov; 34(4):1025-33, x. PubMed ID: 18984420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
